19 Dec 2014 --- Bifodan A/S has announced the initiation of a potentially groundbreaking scientific joint venture to develop a new technology for microencapsulation of probiotic bacteria. Endorsed and co-funded by Innovation Fund Denmark, Bifodan A/S will be joined by University of Copenhagen and Danish Technological Institute in an ambitious effort to be able to deliver probiotics alive for targeted release in the intestinal tract.
